News
Accelerated Bio and Pluristyx create Clinical Grade Induced Pluripotent Stem Cells from Reprogramming Human Trophoblast Stem Cells
Science: There Will Be Blood
Is mimicking the cells that carry hemoglobin the key to a blood substitute?
The UM BioPark is a beacon for early-stage technology ventures
The research park’s perfectly matched location and array of startup-supporting resources makes it an invaluable pillar for a growing number of life science startups — and the entire Maryland ecosystem.
Wellsheet AI-Powered Smart EHR UI Delivers Usability and ROI
– 94% of clinicians recommend for chart review
– 6.3% reduction in length of stay
– 8X+ ROI in first year, delivering ~$8M savings per hospital
– 40%+ reduction in time spent in the EHR
IVIEW Therapeutics Inc. Announces Dosing of First Patient in Phase 1/2 Clinical Trial of IVW-1001 for Dry Eye Disease
Accelerated Biosciences Announces License of its Human Trophoblast Stem Cells (hTSC) to Agathos Biologics for Development of Ethically Sourced Research and Biomanufacturing Platforms
Accelerated Biosciences and Spanios Partner to Advance Therapeutic Design Across Solid Tumor Cancers